Riga Lipid Conference 2025
.
Date: 11/04/2025
Venue: Bellevue Park Hotel Riga (1 Slokas Str., Riga, Latvia)
.
Dear Colleagues and Friends!
A warm welcome to the inaugural Riga Lipid Conference 2025, an international gathering dedicated to celebrating the 10th anniversary of the Latvian Registry of Familial Hypercholesterolemia (FH).
This registry has been a resounding success, significantly improving awareness and management of FH patients in Latvia. We are honored to host this conference in Riga, providing a platform for sharing knowledge, fostering collaborations, and discussing the latest advancements in lipid research and FH management.
The conference will feature dedicated sessions on FH, exploring the latest research and clinical practices. We will also delve into other important lipid topics and discuss alternative approaches to tackling cardiovascular risk.
We are fortunate to have a distinguished lineup of international speakers who will share their expertise and insights. We encourage you to also take the opportunity to explore the beauty of Riga during your time here.
We look forward to a productive and inspiring conference that will advance our understanding and treatment of FH and cardiovascular disease.
Gustavs Latkovskis
Chairman, Riga Lipid Conference 2025
.
PROGRAM
.
8.30 REGISTRATION
9.00 OPENING
9.20 SESSION I
Familial Hypercholesterolemia Registries
Chairs: TBA
9.20 Latvian Registry of FH: ten years of experience. Gustavs Latkovskis (Latvia)
9.45 FH in Lithuania. Zaneta Petrulioniene (Lithuania)
10.00 FH in Estonia. Margus Viigimaa (Estonia)
10:15 Screening and management of pediatric FH. Urh Groseilj (Slovenia)
10.40 Discussion
11.00 COFFEE BREAK
11.30 SESSION II
Familial Hypercholesterolemia
Chairs: TBA
11.30 Genetics of FH, current situation and future perspectives. TBA
11.55 Homozygous FH: clinical approach and international registries. TBA
12.15 Women, lipids and FH. Jeanine Roeters van Lennep (The Netherlands)
12.40 Discussion
13.00 LUNCH
14.00 SESSION III
Hot topics in lipidology
Chairs: TBA
14.00 PCSK9 modulation and other novel lipid-lowering therapies. Maciej Banach (Poland)
14.25 Lipoprotein(a). TBA
14.45 Management of severe and moderate hypertriglyceridemia. TBA
15.00 LDL functionality studies. Simon Pfisterer (Finland)
15.15 Discussion
15.30 COFFEE BREAK
16.00 SESSION IV
Other risk reduction strategies
Chairs: TBA
16.00 Expanding role of SGLT2 inhibitors in cardiovascular prevention. Gustavs Latkovskis (Latvia)
16.20 Insulin Resistance as a Driver of Atherogenic Dyslipidemia: Emerging Solutions. Ilze Konrade (Latvia)
16.50 Microalbuminuria as a cardiovascular risk marker. What are clinical implications? Ieva Ziedina (Latvia)
17.10 Discussion
17.30 CLOSING
REGISTRATION – CLICK HERE
The registration fee payment 20 EUR should be transferred as following:
Latvijas Kardiologu biedriba
Reg. No: 40008004320
SEB banka
Account No: LV65UNLA0003200700293
The payment should clearly state the name of the delegate and the title of the congress: Name, Surname, Registration fee RLC 2025.
